Clinical Trial Details
— Status: Not yet recruiting
Administrative data
NCT number |
NCT04800419 |
Other study ID # |
MFLeong |
Secondary ID |
|
Status |
Not yet recruiting |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
July 1, 2021 |
Est. completion date |
June 30, 2024 |
Study information
Verified date |
March 2021 |
Source |
Universiti Sains Malaysia |
Contact |
Mohammad Farris Iman Leong Bin Abdullah, Dr Psych |
Phone |
+604-5622482 |
Email |
farris[@]usm.my |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Head and neck cancer is a group of biologically similar cancers which cause deleterious
impact, such as the complication of facial disfigurement which may increase the psychological
vulnerability of patients due to the society's emphasis on physical attractiveness. The
appearance of facial disfigurement can increase depression and reduced quality of life (QoL)
in head and neck cancer patients. Among the positive psychology developed in cancer patients
despite their negative experience of cancer and the adverse effects of its treatment are
posttraumatic growth (PTG) and hope which may enhance the QoL of cancer patients. Several
psychosocial interventions have been suggested to enhance positive psychology in cancer
patients and increase in their QoL. Among the psychosocial interventions shown to be
promising include mindfulness-based intervention and newer psychosocial intervention, such as
acceptance and commitment therapy (ACT). Data is lacking on the efficacy of mindfulness-based
stress reduction (MBSR) and acceptance and commitment therapy (ACT) on enhancing positive
psychology (such as PTG, optimism and hope) and QoL, while reducing depression and anxiety
among head and neck cancer patients. This is a multicentre 3-armed longitudinal double blind
randomized control trial aimed to test the study hypotheses of:
1. Head and neck cancer patients in the acceptance and commitment therapy (ACT) group
reported significantly increase in posttraumatic growth (PTG), hope, optimism, and
quality of life as well as significantly reduced depression, anxiety, and experiential
avoidance compared with those in the control group at post-intervention and 6 months
after intervention when compared with pre-intervention.
2. Head and neck cancer patients in the mindfulness-based stress reduction (MBSR) group
reported significantly increase in posttraumatic growth (PTG), hope, optimism, and
quality of life as well as significantly reduced depression, anxiety, and experiential
avoidance compared with those in the control group at post-intervention and 6 months
after intervention when compared with pre-intervention.
3. There are no difference in the increase in posttraumatic growth (PTG), hope, optimism
and quality of life, and decrease in depression, anxiety, and experiential avoidance
between the MBSR and ACT groups at post-intervention and 6 months after intervention.
Description:
As head and neck cancer differ from other types of cancer due to the complication of facial
disfigurement which may increase the psychological vulnerability of patients due to the
society's emphasis on physical attractiveness. Moreover, a number of devastating
complications of the cancer itself and the side effects of its treatment such as fatigue,
pain, problem with speech and swallowing, breathing problem, mucositis, xerostomia, and
trismus which further exerts detrimental effects on many functions and activities of daily
living which causes further psychological distress and decreasing quality of life. Hence, it
is of utmost importance to investigate on psychosocial interventions which could enhance PTG,
hope, optimism and QoL as well as reducing internalized stigma and experiential avoidance of
head and neck cancer patients which in turn bring about the ultimate outcome of restoring
mental and physical well-being of the cancer survivors. Acceptance and commitment therapy
(ACT) and mindfulness-based stress reduction (MBSR) have been reported to enhance positive
psychology and alleviate psychological distress in cancer patients. But the effect of ACT and
MBSR on PTG, hope, optimism, QoL, depression, anxiety and experiential avoidance among head
and neck cancer patients have not been studied. Hence, there is a need to conduct a 3-armed
randomized control trial to evaluate the effects of ACT and MBSR on PTG, hope, optimism, QoL,
internalized stigma and experiential avoidance compared with control group with no
intervention across time.
Below are the objectives of this study:
General objective:
To examine the effects of acceptance and commitment therapy (ACT) and mindfulness-based
stress reduction (MBSR) on posttraumatic growth (PTG), hope, optimism, quality of life,
depression, anxiety, and experiential avoidance among head and neck cancer patients.
Specific objectives:
1. To examine the changes in the degree of posttraumatic growth (PTG), hope, optimism,
quality of life, depression, anxiety, and experiential avoidance of head and neck cancer
patients in the acceptance and commitment therapy (ACT) group compared with those in the
control group at post-intervention, 6 months and 12 months after intervention compared
with pre-intervention.
2. To examine the changes in the degree of posttraumatic growth (PTG), hope, optimism,
quality of life, depression, anxiety, and experiential avoidance of head and neck cancer
patients in the mindfulness-based stress reduction (MBSR) group compared with those in
the control group at post-intervention, 6 months and 12 months after intervention
compared with pre-intervention.
3. To determine whether there are any difference in the changes in the degree of
posttraumatic growth (PTG), hope, optimism, quality of life, depression, anxiety, and
experiential avoidance between those in the acceptance and commitment therapy (ACT)
group and mindfulness-based stress reduction (MBSR) group at post-intervention, 6 months
and 12 months after intervention.
Study Setting:
The study will be conducted the Oncology and Otorhinolaryngology unit of Advanced Medical and
Dental Institute, Universiti Sains Malaysia and Oncology and Otorhinolaryngology unit of
Universiti Kebangsaan Malaysia Medical Centre. The Oncological and Otorhinolaryngology units
of AMDI, USM have about 200-250 registered head and neck cancer patients currently under
follow up. These units receive new cases of head and neck cancer every week. While the
Department of Otorhinolaryngology and Department of Oncology of UKMMC have an estimated
350-400 registered head and neck cancer patients while the Department of Oral and
Maxillofacial Surgery of UKMMC has an estimated 100-150 registered oral cancer patients under
follow up (oral cancer is grouped under head and neck cancer).
Study design:
This is a multicentre 3-armed longitudinal double blind randomized control trial which is
expected to run for a duration of 3 years (from July 2021 to June 2024).
Sample size:
The sample size is determined based on G-Power 3.1.9.2 for repeated measures, between-within
interaction ANOVA. Based on the previous study, the sample size was calculated based on the
continuous response, Post-traumatic growth inventory from the study conducted by Labelle et
al. (2014), with medium effect size (0.23), an alpha of 0.05, two-tailed. The results
indicated that the total sample of 63 for three equal-sized groups is needed to achieve a
power of 0.95. In anticipation of a drop-out rate of 30%, the estimation for sample size is
90 respondents for total respondents and 30 respondents for each group.
Sampling method:
Sampling method use in this study is by consecutive sampling.
Recruitment of subjects:
The participants were recruited from the source population which included all newly diagnosed
head and neck cancer patients who has been treated only with surgery or still remain
untreated registered under the Oncology and Otorhinolaryngology unit of Advanced Medical and
Dental Institute, Universiti Sains Malaysia and Oncology and Otorhinolaryngology unit of
Universiti Kebangsaan Malaysia Medical Centre. These patients will be approached by the
research team and explained on the study objectives and procedures.
Randomization:
Participants will be randomized into three groups, such as acceptance and commitment therapy
(ACT) group, mindfulness-based stress reduction (MBSR) group and control group on waiting
list. The participants will be randomized into one of the three groups in a 1:1:1 allocation
ratio by block randomization. The allocation sequence is concealed in opaque, sequential
numbered envelope.
Data collection:
Data collection is carried out by a research assistant who is not involved in conduct of the
study and data analysis. In the pre-intervention phase (T1), the participants in all three
groups are administered the following questionnaires:
(i) Socio-demographic and clinical questionnaire which includes age, gender, marital status,
employment, education, monthly income, religion, stage of cancer and type of head and neck
cancer.
(ii) The Posttraumatic Growth Inventory-Short Form (PTGI-SF) to assess the degree of PTG of
the participants (iii) The Dispositional Hope Scale to assess the degree of hope of the
participants (iv) The Hospital Anxiety and Depression Scale (HADS) to assess the severity of
depressive and anxiety symptoms (v) The Life Orientation Test-Revised (LOT-R) to assess the
degree of optimism (vi) The Acceptance and Action Questionnaire (AAQ-II) to assess the degree
of experiential avoidance (vii) The Functional Assessment of Cancer Therapy - Head & Neck
(FACT-H & N) to assess the degree of quality of life
Then the assessments with the following questionnaires are repeated immediately
post-intervention (T2) and 6 months after intervention (T3) among participants in all the
three groups:
(i) The Posttraumatic Growth Inventory-Short Form (PTGI-SF) to assess the degree of PTG of
the participants (ii) The Dispositional Hope Scale to assess the degree of hope of the
participants (iii) The Hospital Anxiety and Depression Scale (HADS) to assess the severity of
depressive and anxiety symptoms (iv) The Life Orientation Test-Revised (LOT-R) to assess the
degree of optimism (v) The Acceptance and Action Questionnaire (AAQ-II) to assess the degree
of experiential avoidance (vi) The Functional Assessment of Cancer Therapy - Head & Neck
(FACT-H & N) to assess the degree of quality of life
Blinding:
The participants will be blinded for the study as randomization into designated groups are
conducted by a research assistant not involved in the study and the allocation is concealed
in opaque, sequential numbered envelope. Therefore, the participants will not know which
group they are allocated to. Although participants in the ACT and MBSR groups undergo
psychosocial intervention earlier, the participants in the control group (who are assigned in
the waitlist) will also undergo ACT once they have completed assessments at three-time frames
(T1, T2, and T3). All the participants will also be blinded regarding the hypotheses of the
study.
The researchers will be blinded for the study as randomization of participants into
designated groups are conducted by a research assistant not involved in the conducting the
study and data analysis. Data collection will also be caried out by the research assistant
who is not involved in conducting the study and data analysis and blinded regarding the
hypotheses of the study. Moreover, the data analysis will be performed out by statisticians
who are not involved in conducting the study and blinded regarding the hypotheses of the
study.
Interventions:
Both ACT and MBSR intervention will be conducted in a group of 10 for each session. The ACT
and MBSR modules covered over 8 sessions, 1 hour in each session. The sessions will be held
every week according to the patient's appointment date for chemotherapy treatment.
Therapists:
The trainee therapists are two post-graduate students who enrolled in their Doctor of
Philosophy (Ph.D.) in psychology. They received training approximately 16 hours of ACT
intervention and 16 hours of MBSR intervention. In ACT intervention training, trainee
therapists will learn about general core concepts of ACT, principals, model, framework, and
philosophy. Besides, they also will learn how to apply ACT therapy including engagement with
each element in hexaflex, integrating exercises, metaphors, techniques, and mindfulness in
ACT sessions and clinical practices. In the MBSR training, the trainee therapists will learn
the basic overview and concepts of MBSR including mindfulness, body scan and yoga. Besides,
they also will experiential learning about formal and informal practices, recording and home
practices.
Data analysis:
Data analysis will be performed using SPSS version 26 software. Descriptive statistics will
be used to analyze demographic data while inference analyses will be used to evaluate the
significant difference between intervention and waitlist groups. In order to identify the
efficacy of acceptance and commitment therapy (ACT) and mindfulness-based stress reduction
(MBSR) on the measured variables, several tests will be carried out. The comparison of mean
differences pre-intervention (T1), post-treatment (T2) and 6 months after intervention (T3)
will be examined to determine whether any changes in the measured variables (PTG, hope,
optimism, QoL, depression, anxiety, and experiential avoidance) in the ACT, MBSR and control
groups across the three timelines by using repeated measure ANOVA. Then, the mean differences
of measured variables (PTG, hope, optimism, QoL, depression, anxiety, and experiential
avoidance) between ACT, MBSR and control groups at each timeline will be determined by using
the one-way ANOVA. The effect sizes will be calculated to determine how substantially
patients' perception towards measured variables changed with and without ACT and MBSR
interventions. Statistical significance is set at p < 0.05 and two-tailed.